Pathkey.ai Ltd (ASX: PKY) — Company Overview, News & Financial Data
Pathkey.
Pathkey.ai Ltd
Pathkey.ai Ltd is a technology investment and development company specializing in applied artificial intelligence and advanced computing applications across specialized technical sectors. The company operates dedicated business units focused on target industry transformations where digital systems can improve operational efficiency. Its primary operations include developing automated hardware description tools for semiconductor engineering and generating predictive simulation models for pharmaceutical clinical trial planning. Headquartered in Sydney, New South Wales, the organization develops proprietary artificial intelligence models that convert functional requirements into verified hardware designs and analyze decades of historical medical trial data to optimize study protocols before physical execution.
Snapshot
Operations
Products and/or services of Pathkey.ai Ltd
- Semiconductor Design Automation: Development and deployment of artificial intelligence tools that convert high-level functional intent into verified register-transfer level hardware design code, utilizing automated verification loops to accelerate field-programmable gate array and application-specific integrated circuit development.
- Clinical Trial Predictive Analytics: Provision of artificial intelligence software for clinical trial design that analyzes historical study data to predict trial outcomes, simulate clinical procedures, and optimize trial protocols prior to live human testing.
Pathkey.ai Ltd executive team
- Mr. Damon RasheedFounder, CTO & Executive Director
- Mr. Mark ZiirsenChief Financial Officer
- Bernice AverionHead of Marketing & Communications
- Mr. Shane LewisVice President of Sales & Partnerships
- Mr. Matt HallamChief Revenue Officer
- Mr. Jonathan Hart B.Com., L.L.B.Company Secretary